Eli Lilly

Industries Pharmaceuticals Biotechnology and Life Sciences
Subsidiaries Morphic Holding, Inc.

Headquartered in Indianapolis, Indiana, Eli Lilly is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. David A. Ricks serves as CEO/President and Chairman, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $385,250 to Republican causes and $113,137 to Democratic causes. Under their tenure, Eli Lilly currently holds a ‘High’ rating.

Business Roundtable
CEO Action Pledge
OneTen Coalition

Company Leadership

David A. Ricks
CEO & Chairman at Eli Lilly

David A. Ricks

Mr. David A. Ricks, also known as Dave, has been a Director of Adobe Inc. since April 12, 2018 and previously served as its Director since June 2017. He served as a Director of Elanco Animal Health Incorporated since 2018 until March 2019. He has been the Chief Executive Officer and President of Eli Lilly and Company since January 1, 2017 and has been its Chairman since June 1, 2017.

Political Contributions of Leadership

Republican Support
Democratic Support
$385,250 $113,137

Leadership

No photo: David A. Ricks
Exec. Board

Chairman and CEO

David A. Ricks

No photo: Juan R. Luciano
Exec. Board

Chairman, President, and CEO

Juan R. Luciano

No photo: Alonzo Weems
Exec.

Exec VP, Enterprise Risk Management, and Chief Ethics and Compliance Officer, Eli Lilly and Company

Alonzo Weems

Anat Ashkenazi
Exec.

Exec VP and CFO, Eli Lilly and Company

Anat Ashkenazi

Anat Hakim
Exec.

Exec VP, General Counsel and Secretary, Eli Lilly and Company

Anat Hakim

Anne E. White
Exec.

Exec VP and President, Lilly Neuroscience, Eli Lilly and Company

Anne E. White

Daniel M. Skovronsky, M.D., Ph.D.
Exec.

Exec VP, Chief Scientific and Medical Officer, and President, Lilly Research Laboratories, Eli Lilly and Company

Daniel M. Skovronsky, M.D., Ph.D.

Diogo Rau
Exec.

Exec VP and Chief Information and Digital Officer, Eli Lilly and Company

Diogo Rau

Edgardo Hernandez
Exec.

Exec VP and President, Manufacturing Operations, Eli Lilly and Company

Edgardo Hernandez

Eric Dozier
Exec.

Exec VP, HR and Diversity, Eli Lilly and Company

Eric Dozier

Ilya Yuffa
Exec.

Exec VP and President, Lilly International, Eli Lilly and Company

Ilya Yuffa

Jacob Van Naarden
Exec.

Exec VP, Eli Lilly and Company and President, Loxo@Lilly

Jacob Van Naarden

Michael B. Mason
Exec.

Exec VP and President, Lilly Diabetes, Eli Lilly and Company

Michael B. Mason

Patrik Jonsson
Exec.

Exec VP; President, Lilly Immunology; President, Lilly USA; and Chief Customer Officer, Eli Lilly and Company

Patrik Jonsson

No photo: Jon Erik Fyrwald
Board

Board Member

Jon Erik Fyrwald

No photo: Karen M. Walker
Board

Board Member

Karen M. Walker

No photo: Katherine Baicker
Board

Board Member

Katherine Baicker

No photo: Kimberly H. Johnson
Board

Board Member

Kimberly H. Johnson

No photo: Marschall S. Runge
Board

Board Member

Marschall S. Runge

No photo: Mary Lynne Hedley
Board

Board Member

Mary Lynne Hedley

Jamere Jackson
Board

Board Member

Jamere Jackson

Ralph Alvarez
Board

Board Member

Ralph Alvarez

No photo: William G. Kaelin
Board

Board Member

William G. Kaelin

Gabrielle E. Sulzberger
Board

Board Member

Gabrielle E. Sulzberger